CellWell record HH-539939
Microbiome as a prediction of immunotherapy response in lung cancer
Leonardo Rojas; Jairo Zuluaga; Andrés F Cardona
2026
In plain language
Higher gut microbial diversity and beneficial taxa were linked to longer progression-free and overall survival in lung cancer patients receiving immune checkpoint inhibitors, while antibiotics and proton pump inhibitors were associated with poorer survival.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-539939
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.